Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,555.50
+15.50 (0.61%)
Sep 18, 2025, 1:44 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Skin Care | 190.49B | Log In | Log In | Log In | Log In | Upgrade |
Skin Care Growth | 7.73% | Log In | Log In | Log In | Log In | Upgrade |
Eye Care | 55.76B | Log In | Log In | Log In | Log In | Upgrade |
Eye Care Growth | 4.41% | Log In | Log In | Log In | Log In | Upgrade |
Oral Medication | 49.36B | Log In | Log In | Log In | Log In | Upgrade |
Oral Medication Growth | 59.74% | Log In | Log In | Log In | Log In | Upgrade |
Other | 13.03B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 33.98% | Log In | Log In | Log In | Log In | Upgrade |
Other | 13.03B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 33.98% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Other | 3.37B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 20.82% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 164.99B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 5.19% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 100.34B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 27.41% | Log In | Log In | Log In | Log In | Upgrade |
America | 20.77B | Log In | Log In | Log In | Log In | Upgrade |
America Growth | 11.87% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 19.16B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 38.02% | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.37B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 20.82% | Log In | Log In | Log In | Log In | Upgrade |